112 related articles for article (PubMed ID: 4323223)
1. [Action of polyriboinosinic acid-polyribocytidylic acid bicatenary complex (poly I:C) on infection caused by various viruses in mice].
Cherby J; Werner GH
Ann Inst Pasteur (Paris); 1970 Dec; 119(6):756-60. PubMed ID: 4323223
[No Abstract] [Full Text] [Related]
2. Chemotherapy of virus diseases.
Diana GD; Pancic F
Angew Chem Int Ed Engl; 1976 Jul; 15(7):410-6. PubMed ID: 182044
[No Abstract] [Full Text] [Related]
3. Inducers of interferon and host resistance. VI. Antiviral efficacy of poly I:C in animal models.
Nemes MM; Tytell AA; Lampson GP; Field AK; Hilleman MR
Proc Soc Exp Biol Med; 1969 Nov; 132(2):776-83. PubMed ID: 5355140
[No Abstract] [Full Text] [Related]
4. Antiviral agents: the road from scepticism to efficacy.
Galasso GJ
Acta Microbiol Acad Sci Hung; 1981; 28(3):313-24. PubMed ID: 6171143
[No Abstract] [Full Text] [Related]
5. Effect of treatment with exogenous interferon, polyriboinosinic-polyribocytidylic acid, or polyriboinosinic-polyribocytidylic acid-poly-L-lysine complex on Herpesvirus hominis infections in mice.
Olsen GA; Kern ER; Overall JC
J Infect Dis; 1978 Apr; 137(4):428-36. PubMed ID: 206632
[TBL] [Abstract][Full Text] [Related]
6. Foot-and-mouth disease virus inhibition induced in mice by synthetic double-stranded RNA (polyriboinosinic and polyribocytidylic acids).
Richmond JY; Hamilton LD
Proc Natl Acad Sci U S A; 1969 Sep; 64(1):81-6. PubMed ID: 4312754
[TBL] [Abstract][Full Text] [Related]
7. [Viruses and antiviral drug resistance].
Hovi T; Järvinen A; Pyhälä R; Ristola M; Salminen M
Duodecim; 2002; 118(9):911-8. PubMed ID: 12238169
[No Abstract] [Full Text] [Related]
8. [Antiviral chemotherapy in dermatology. Action of N1, N1 anhydrobis (beta-hydroxyethyl) biguanide hydrochloride in high doses].
Rivoire J
Lyon Med; 1967 Dec; 218(52):1699-705. PubMed ID: 4316652
[No Abstract] [Full Text] [Related]
9. Advances in the treatment of virus diseases.
Rubenstein D; Tyrrell DA
Practitioner; 1971 Oct; 207(240):510-5. PubMed ID: 4332181
[No Abstract] [Full Text] [Related]
10. Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. I. Effect of single doses of polyriboinosinic-polyribocytidylic acid and tilorone hydrochloride on viral pathogenesis.
Stringfellow DA; Overall JC; Glasgow LA
J Infect Dis; 1974 Nov; 130(5):470-80. PubMed ID: 4371528
[No Abstract] [Full Text] [Related]
11. [Use of new antiviral preparations, nuclease enzymes, in neuroviral infections].
Lobzin VS; Sichko ZhV
Voen Med Zh; 1973 Aug; (8):47-50. PubMed ID: 4375882
[No Abstract] [Full Text] [Related]
12. Herpesvirus saimiri: in vitro sensitivity to virus-induced interferon and to polyriboinosinic acid: polyribocytidylic acid.
Barahona HH; Melendez LV
Proc Soc Exp Biol Med; 1971 Apr; 136(4):1163-7. PubMed ID: 4324740
[No Abstract] [Full Text] [Related]
13. Intranasal challenge of mice with herpes simplex virus: an experimental model for evaluation of the efficacy of antiviral drugs.
De Clercq E; Luczak M
J Infect Dis; 1976 Jun; 133 Suppl():A226-36. PubMed ID: 180205
[TBL] [Abstract][Full Text] [Related]
14. Use of poly I-poly C in the prophylaxis and treatment of acute viral infections.
Hilleman MR
Bull World Health Organ; 1969; 41(3):696-7. PubMed ID: 5309495
[No Abstract] [Full Text] [Related]
15. Prophylaxis of experimental rabies with the polyriboinosinic-polyribocytidylic acid complex.
Fenje P; Postic B
J Infect Dis; 1971 Apr; 123(4):426-8. PubMed ID: 5110740
[No Abstract] [Full Text] [Related]
16. Advances in antiviral chemotherapy.
King DH
J Am Vet Med Assoc; 1984 Nov; 185(10):1115-7. PubMed ID: 6096322
[No Abstract] [Full Text] [Related]
17. Rabies in rabbits and mice: protective effect of polyriboinosinic-polyribocytidylic acid.
Janis B; Habel K
J Infect Dis; 1972 Apr; 125(4):345-52. PubMed ID: 4553077
[No Abstract] [Full Text] [Related]
18. Role of nucleosides in virus and cancer chemotherapy.
Prusoff WH; Chen MS; Fischer PH; Lin TS; Shiau GT; Schinazi RF
Adv Ophthalmol; 1979; 38():3-16. PubMed ID: 230724
[No Abstract] [Full Text] [Related]
19. Pharmacology of polyriboinosinic: polyribocytidylic acid, a new antiviral and antitumor agent.
Adamson RH; Fabro S; Homan ER; O'Gara RW; Zendzian RP
Antimicrob Agents Chemother (Bethesda); 1969; 9():148-52. PubMed ID: 4990370
[No Abstract] [Full Text] [Related]
20. Antiviral activity of BL-3849A, a low-molecular-weight oral interferon inducer.
Kern ER; Hamilton JR; Overall JC; Glasgow LA
Antimicrob Agents Chemother; 1976 Oct; 10(4):691-6. PubMed ID: 185953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
